THBS1 and ovarian serous cystadenocarcinoma: Cox-DSS data revealed that low THBS1-IT1 expression had relative better prognosis in patients of ACC, BLCA, GBM, HNSC, KIRC, LGG, ovarian serous cystadenocarcinoma (OV), PAAD and STAD (Supplementary Figure 8, HR > 1, P < 0.05).